Product Description: Nucleozin, a potent inhibitor of influenza A virus infection, induces the formation of nucleoprotein (NP) aggregates and antagonizes its nuclear accumulation, leading to cessation of viral replication. Nucleozin impedes influenza A virus replication in vitro with a nanomolar EC50[1].
Applications: COVID-19-anti-virus
Formula: C21H19ClN4O4
References: [1]Kao RY, et al. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol. 2010;28(6):600-605.
CAS Number: 341001-38-5
Molecular Weight: 426.85
Compound Purity: 99.66
Research Area: Infection
Solubility: DMSO : 20 mg/mL (ultrasonic)
Target: Influenza Virus